Kannan Vishwanath Latvia

Kannan K Vishwanath , a prominent figure in the field of international business and pharmaceuticals, recently delivered a captivating speech at the Pharma Summit & Awards 2021 organized by the esteemed Latvian Academy of Sciences. With an audience of distinguished industry veterans, his address shed valuable light on the profound impact of the COVID-19 pandemic on global business, particularly within the pharmaceutical sector. Dr. Vishwanath's insights focused on the crucial role of pharmaceutical products and vaccines in shaping human well-being, emphasizing the opportunities they present amidst the challenges posed by the pandemic. During his speech, Dr. Vishwanath also delved into the evolving dynamics of business accountability, drawing inspiration from the teachings of the renowned economist Milton Friedman from over half a century ago. By providing a historical perspective on corporate responsibility, he offered a thought-provoking analysis of how businesses can navigate ...

      The pharmaceutical industry has experienced a slowdown in growth in recent years due to current medicines reaching saturation levels in many markets. This has emphasized the need for the industry to invest in new drug development and gain a better understanding of the reasons behind falling drug sales, especially in emerging markets. To move forward successfully, it is essential for the industry to identify the market potential for new drugs and pinpoint the factors affecting sales. To achieve this, the pharmaceutical industry must adopt a 'big picture' or horizontal approach. This means looking beyond individual components and considering the broader landscape. By taking this approach, the industry can develop a comprehensive understanding of the various factors that impact drug sales, both internally and externally. The healthcare industry is shifting towards a patient-centric care model, recognizing the importance of meeting patient needs and preferences. However...

                    The pharmaceutical industry has experienced a slowdown in growth in recent years due to the saturation of existing medicines in the market. To address this challenge, the industry must invest in new drug development while also understanding and counteracting the decline in drug sales in emerging markets. This requires identifying the market potential for new drugs and determining the factors influencing declining sales. Taking a 'big picture' or horizontal approach is essential for the industry to move forward successfully. By considering the broader context and interconnections between various aspects of drug development and sales, pharmaceutical companies can make informed decisions and develop comprehensive strategies. The healthcare industry is shifting towards a patient-centric care model, but the pharmaceutical customer base is diverse, including hospital managers, doctors, pharmacists, patients, and caregivers....